Znn3bq.jpeg
²é¿´: 4073  |  »Ø¸´: 36

273155391

½ð³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
½¨ÒéÂ¥Ö÷ÏÈ¿´¿´¸ÃÆÚ¿¯µÄͶ¸åÐëÖª£¬¿´ÀïÃæÊÇÔõôҪÇóµÄ¡£Èç¹ûÒªÌí¼Ó£¬×îºÃÏò±à¼­ËµÃ÷£¬²¢Ö®´¦XXXÔÚÂÛÎĵÄÄÄЩ¹¤×÷ÖУ¨±ÈÈç´óÐ޵IJ¹³äʵÑé¡¢ÂÛÎÄÐ޸ĵȵȣ©×÷³öÁËÖØÒª¹±Ï×
21Â¥2013-01-31 12:39:03
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ll9999

ר¼Ò¹ËÎÊ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÍêÈ«¿ÉÒÔ£¬Ö»ÊÇÓ¦¸Ã¸æË߱༭һÏÂ
22Â¥2013-01-31 13:07:00
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

klosexs1987

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
ÎÄÕÂÖÐËùÓи͝µÄµØ·½È«²¿¶¼Òªmark£¬²¢ËµÃ÷Ô­Òò¡£Õâ¸öÊÇ×î»ù±¾µÄ¡£ÁíÍâÉæ¼°µ½¸ü¸Ä£¬Ìí¼Ó×÷Õߣ¬Õâ¸ö¾ÍÉæ¼°µ½¸÷·½ÀûÒæ¡£ËùÒÔÊ×ÏȱØÐë¸ú±à¼­ËµÃ÷Çå³þ£¬ÄÇÈ˵ÄcontributionÔÚÄÄ¡£Í¬Ê±£¬±ØÐëµÃµ½ËùÓÐ×÷ÕßµÄͬÒ⣬ËùÓÐ×÷ÕßµÄÇ©ÃûͬÒâÊDZØÐëµÄ¡£Ò»°ãºÃµãµÄsci,EIÆÚ¿¯¶¼»á˵µÃºÜÇå³þ¡£
23Â¥2013-01-31 13:41:50
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

klosexs1987

½ð³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial,
personal or other relationships with other people or organizations within three years of beginning the
submitted work that could inappropriately influence, or be perceived to influence, their work. See
also http://www.elsevier.com/conflictsofinterest.
Examples of potential conflicts of interest include employment, consultancies, stock ownership,
honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except
in the form of an abstract or as part of a published lecture or academic thesis), that it is not
under consideration for publication elsewhere, that its publication is approved by all authors and
tacitly or explicitly by the responsible authorities where the work was carried out, and that,
if accepted, it will not be published elsewhere in the same form, in English or in any other
language, including electronically without the written consent of the copyright-holder. To verify
originality, your article may be checked by the originality detection software iThenticate. See also
http://www.elsevier.com/editors/plagdetect.
Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have
materially participated in the research and/or article preparation, so roles for all authors should be
described. The statement that all authors have approved the final article should be true and included
in the disclosure.
Authorship
All authors should have made substantial contributions to all of the following: (1) the conception and
design of the study, or acquisition of data, or analysis and interpretation of data, (2) drafting the
article or revising it critically for important intellectual content, (3) final approval of the version to
be submitted.
Changes to authorship
This policy concerns the addition, deletion, or rearrangement of author names in the authorship of
accepted manuscripts:
Before the accepted manuscript is published in an online issue: Requests to add or remove an author,
or to rearrange the author names, must be sent to the Journal Manager from the corresponding author
of the accepted manuscript and must include: (a) the reason the name should be added or removed,
or the author names rearranged and (b) written confirmation (e-mail, fax, letter) from all authors that
they agree with the addition, removal or rearrangement. In the case of addition or removal of authors,
this includes confirmation from the author being added or removed. Requests that are not sent by
the corresponding author will be forwarded by the Journal Manager to the corresponding author, who
must follow the procedure as described above. Note that: (1) Journal Managers will inform the Journal
Editors of any such requests and (2) publication of the accepted manuscript in an online issue is
suspended until authorship has been agreed.
After the accepted manuscript is published in an online issue: Any requests to add, delete, or rearrange
author names in an article published in an online issue will follow the same policies as noted above
and result in a corrigendum.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for
more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the
agreement will ensure the widest possible dissemination of information. An e-mail will be sent to
the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing
Agreement' form or a link to the online version of this agreement.
Authors whose articles are published in the International Journal for Parasitology will be asked to
transfer copyright for that article to the Australian Society for Parasitology, Inc. If there are any issues
or conflicts of interest which might prevent the author transferring copyright, they should inform the
Editor when submitting the manuscript.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal
circulation within their institutions. Permission of the Publisher is required for resale or distribution
outside the institution and for all other derivative works, including compilations and translations
(please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are
AUTHOR INFORMATION PACK 14 Jul 2011 www.elsevier.com/locate/ijpharm 6
included, the author(s) must obtain written permission from the copyright owners and credit the
source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult
http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred
to: http://www.elsevier.com/authorsrights.
Õâ¸öÊÇinternational journal of pharmaceuticsµÄguide of authors£¬ÀïÃæ¾ÍºÜÏêϸµÄÌá¹ý×÷Õ߱䶯£¬ÒÔ¼°Ïà¹ØÀûÒæ¹ØÏµ£¬LZ¿ÉÒÔ¿´¿´£¡
24Â¥2013-01-31 13:49:09
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liuwei0551

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¿ÉÒԵġ£Ò»°ã±à¼­Ö»×¢ÒâÎÄÕÂÖÐÉó¸åÈËÌáµ½µÄ²¿·Ö¡£
25Â¥2013-01-31 22:39:01
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zhixuonline

ľ³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¹úÄÚÆÚ¿¯¾Íû¹ØÏµ£¬Èç¹û±à¼­ÓÐÒâ¼ûµÄ»°£¬Äã¾Í¸ã¸öÇ©ÃûÐÅɨÃè¼þ·¢¹ýÈ¥¾ÍÐÐÁË
¹úÍâÌí¼Ó×÷Õߵϰ£¬Ò²Èç´Ë
26Â¥2013-02-01 01:01:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

¹ýÕ³Õ³

Òø³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
µ±È»¿ÉÒÔÁË£¬²»¹ý¼ÇµÃÒª¸ú±à¼­ËµÒ»Éù
27Â¥2013-02-01 09:37:04
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

padodo

ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)

ÅÖà½à½

ÓÅÐã°æÖ÷

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
Ö±½Ó¼Ó¾ÍÐУ¬²»ÐèÒª½âÊÍ£¬Ô½½âÊÍÊÂÔ½¶à
ÎÒÓÐʲôÄܰïÖúÄúµÄÂð£¿
28Â¥2013-02-01 09:38:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

lrwm841123

Í­³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
¿Ï¶¨µÃ˵Ã÷£¬²»ËµÃ÷ÊDz»Ðеġ£
29Â¥2013-02-01 11:24:30
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

liaowb03

ÖÁ×ðľ³æ (ÖªÃû×÷¼Ò)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
»¹Ã»½ÓÊÜ֮ǰ£¬¼Ó×÷Õ߾Ͳ»ÐèҪ˵Á˰ɣ¬²»È»¾Í¶àÊÂÁË¡£
ºÇºÇ£¬×£¸£~£¡
30Â¥2013-02-01 12:13:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ txyamy µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 270Çóµ÷¼Á +5 ÑîÀÖ369 2026-04-11 5/250 2026-04-11 12:24 by Sealedwind
[¿¼ÑÐ] 086000µ÷¼Á +5 Ê®Æßsa 2026-04-07 5/250 2026-04-11 10:38 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] 085404 293Çóµ÷¼Á +9 ÓÂÔ¶¿â°®314 2026-04-06 10/500 2026-04-11 10:36 by ×ÏêØ×ÏÆå
[¿¼ÑÐ] 302·ÖÇóµ÷¼Á +9 ·²ÓïÆíÔ¸ 2026-04-08 10/500 2026-04-10 23:26 by 314126402
[¿¼ÑÐ] ²ÄÁÏ085601µ÷¼Á +25 ºÎÈó²É123 2026-04-10 27/1350 2026-04-10 23:17 by Ftglcn90
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£©×ö¹ý·Ö×ÓʵÑé +8 ÏàÐűػá¹ââÍòÕ 2026-04-07 9/450 2026-04-10 21:03 by zhouxiaoyu
[¿¼ÑÐ] 085800 ÄÜÔ´¶¯Á¦Çóµ÷¼Á +6 °¢biu°¡°¡°¡°¡°¡ 2026-04-10 6/300 2026-04-10 15:03 by hemengdong
[¿¼ÑÐ] 344Çóµ÷¼Á +7 ؼ·çѩҹ¹éÈËØ¼ 2026-04-09 7/350 2026-04-10 12:05 by pengliang8036
[¿¼ÑÐ] 368»¯Ñ§Çóµ÷¼Á +13 wwwwabcde 2026-04-07 14/700 2026-04-09 14:47 by heaven_jay
[¿¼ÑÐ] Çóµ÷¼Á +3 ÖíÈâ¶Õ·ÛÌõcc 2026-04-08 4/200 2026-04-09 10:05 by ÖíÈâ¶Õ·ÛÌõcc
[¿¼ÑÐ] 270Çóµ÷¼Á +3 031127 2026-04-06 4/200 2026-04-08 21:00 by ÄæË®³Ë·ç
[¿¼ÑÐ] ¼ÆËã»ú11408 287 Çóµ÷¼Á +3 LiLe5 2026-04-07 3/150 2026-04-07 23:15 by shanqishi
[¿¼ÑÐ] 277Çóµ÷¼Á ÊýÒ»104·Ö +9 Æ¿×ÓPZ 2026-04-05 14/700 2026-04-07 17:52 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á +10 cs0106 2026-04-05 12/600 2026-04-06 19:41 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 362Çóµ÷¼ÁÒ»Ö¾Ô¸ÖйúʯÓÍ´óѧ +4 ÎÒÒª¿¼´ó 2026-04-06 6/300 2026-04-06 14:11 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 331Çóµ÷¼Á +8 ÓÚÕ÷yz 2026-04-05 8/400 2026-04-06 00:54 by fmesaito
[¿¼ÑÐ] 302·Ö 085601Çóµ÷¼ÁÍÆ¼ö +11 zyxÉϰ¶£¡ 2026-04-05 11/550 2026-04-05 22:13 by dongzh2009
[¿¼ÑÐ] ÇóÉúÎïѧѧ˶µ÷¼Á¡ª¡ª364·Ö +7 ÔÆ¶äåÞÍäÖ¸ÄÏ 2026-04-04 7/350 2026-04-04 22:49 by zhyzzh
[¿¼ÑÐ] 320Çóµ÷¼Á +3 Ò»ÑùÔ² 2026-04-04 3/150 2026-04-04 22:29 by à£à£à£0119
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÅ©090401£¬268£¬Çóµ÷¼Á +5 һľÄñÈ» 2026-04-04 5/250 2026-04-04 17:07 by babysonlkd
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û